HIGHLIGHTS
- who: Piero Ruscitti from the (UNIVERSITY) have published the Article: Efficacy of inhibition of IL-1 in patients with rheumatoid arthritis and type 2 diabetes mellitus: two case reports and review of the literature, in the Journal: (JOURNAL)
- what: The authors report the positive effects of the inhibition of interleukin-1 in two patients with rheumatoid arthritis associated with type 2 diabetes_mellitus, with both reaching the therapeutic targets of their diseases by using a single biological agent and tapering or discontinuing their antidiabetic therapies. The authors show that anakinra, prescribed for the treatment of relapsing . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.